BR112017013194A2 - síntese total de trioxacarcina dc-45-a2 e preparação de análogos de trioxacarcina - Google Patents

síntese total de trioxacarcina dc-45-a2 e preparação de análogos de trioxacarcina

Info

Publication number
BR112017013194A2
BR112017013194A2 BR112017013194-3A BR112017013194A BR112017013194A2 BR 112017013194 A2 BR112017013194 A2 BR 112017013194A2 BR 112017013194 A BR112017013194 A BR 112017013194A BR 112017013194 A2 BR112017013194 A2 BR 112017013194A2
Authority
BR
Brazil
Prior art keywords
trioxacarcin
preparation
analogs
total synthesis
methods
Prior art date
Application number
BR112017013194-3A
Other languages
English (en)
Inventor
C. Nicolaou Kyriacos
Cai Quan
Original Assignee
William Marsh Rice University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Marsh Rice University filed Critical William Marsh Rice University
Publication of BR112017013194A2 publication Critical patent/BR112017013194A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)

Abstract

em um aspecto, a presente invenção fornece novos derivados de análogos de trioxacarina de fórmula (i) em que as variáveis são como definidas aqui. o pedido ainda fornece composições, métodos de tratamento e métodos de síntese dos mesmos.
BR112017013194-3A 2014-12-19 2015-12-18 síntese total de trioxacarcina dc-45-a2 e preparação de análogos de trioxacarcina BR112017013194A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462094662P 2014-12-19 2014-12-19
US62/094,662 2014-12-19
US201562186128P 2015-06-29 2015-06-29
US62/186,128 2015-06-29
PCT/US2015/066703 WO2016100833A2 (en) 2014-12-19 2015-12-18 Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs

Publications (1)

Publication Number Publication Date
BR112017013194A2 true BR112017013194A2 (pt) 2018-01-02

Family

ID=56127867

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013194-3A BR112017013194A2 (pt) 2014-12-19 2015-12-18 síntese total de trioxacarcina dc-45-a2 e preparação de análogos de trioxacarcina

Country Status (23)

Country Link
US (1) US10899773B2 (pt)
EP (1) EP3233877A4 (pt)
JP (1) JP2017537968A (pt)
KR (1) KR20170122718A (pt)
CN (1) CN107250144A (pt)
AU (1) AU2015364347A1 (pt)
BR (1) BR112017013194A2 (pt)
CA (1) CA2970955A1 (pt)
CL (1) CL2017001599A1 (pt)
CO (1) CO2017007074A2 (pt)
CR (1) CR20170331A (pt)
DO (1) DOP2017000144A (pt)
EA (1) EA201791388A1 (pt)
EC (1) ECSP17046657A (pt)
GT (1) GT201700139A (pt)
HK (1) HK1243422A1 (pt)
IL (1) IL252947A0 (pt)
MA (1) MA41216A (pt)
MX (1) MX2017008162A (pt)
PE (1) PE20171787A1 (pt)
PH (1) PH12017501147A1 (pt)
SG (1) SG11201704935XA (pt)
WO (1) WO2016100833A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019036537A1 (en) * 2017-08-17 2019-02-21 William Marsh Rice University ANALOGUES AND DIMER OF TRIOXACARCIN AS POWERFUL ANTICANCER AGENTS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815995A (ja) 1981-07-22 1983-01-29 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５−ａ↓１およびｄｃ−４５−ａ↓２ならびにそれらの製造法
EP0157203A3 (en) 1984-04-04 1986-10-01 American Cyanamid Company Antitumor agents ll-d49194 alpha 1, ll-d49194 beta, ll-d49194 beta 2, ll-d49194 upsilon, ll-d49194 delta, ll-d49194 epsilon, ll-d49194 zeta, and ll-d49194 eta
JPS63135389A (ja) 1986-11-26 1988-06-07 Kyowa Hakko Kogyo Co Ltd Ｄｃ−４５類の誘導体
WO2011119549A1 (en) 2010-03-22 2011-09-29 President And Fellows Of Harvard College Trioxacarcins and uses thereof
WO2014082065A1 (en) 2012-11-26 2014-05-30 President And Fellows Of Harvard College Trioxacarcins, trioxacarcin-antibody conjugates, and uses thereof

Also Published As

Publication number Publication date
US10899773B2 (en) 2021-01-26
MX2017008162A (es) 2018-03-06
EA201791388A1 (ru) 2017-11-30
CO2017007074A2 (es) 2017-10-20
US20190023717A1 (en) 2019-01-24
HK1243422A1 (zh) 2018-07-13
AU2015364347A1 (en) 2017-07-13
SG11201704935XA (en) 2017-07-28
WO2016100833A2 (en) 2016-06-23
MA41216A (fr) 2017-10-24
CA2970955A1 (en) 2016-06-23
PE20171787A1 (es) 2017-12-28
KR20170122718A (ko) 2017-11-06
ECSP17046657A (es) 2019-03-29
EP3233877A4 (en) 2018-10-17
EP3233877A2 (en) 2017-10-25
CL2017001599A1 (es) 2018-11-09
CN107250144A (zh) 2017-10-13
CR20170331A (es) 2017-11-17
GT201700139A (es) 2018-10-24
PH12017501147A1 (en) 2018-03-05
DOP2017000144A (es) 2017-09-29
WO2016100833A3 (en) 2017-01-05
JP2017537968A (ja) 2017-12-21
IL252947A0 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
ECSP17073191A (es) Compuestos heterocíclicos como inhibidores de lsd1
BR112018003343A2 (pt) compostos heteroarila como inibidores de irak e usos dos mesmos
BR112017006305A2 (pt) compostos heteroarila como inibidores de btk e usos dos mesmos
BR112018016433A2 (pt) inibidores de heteroarila de pad4
BR112018003812A2 (pt) compostos de heteroarila como inibidores de irak e usos dos mesmos
BR112016014020A8 (pt) moduladores de tetra-hidropiridopirazinas de gpr6.
BR112017012272A2 (pt) derivados de 2-anilinopirimidina como moduladores de egfr
BR112016023558A2 (pt) compostos úteis como imunomoduladores
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
UY36705A (es) Compuestos de 4-hidroxi-3-(heteroaril)piridin-2-ona como agonistas de apj
BR112018007395A2 (pt) 2,4-di-hidróxi-nicotinamidas como agonistas de apj
BR112018012112A2 (pt) heteroaril-hidroxipirimidinonas como agonistas do receptor apj
BR112016029333A2 (pt) síntese de compostos de carbamoilpiridona policíclico
BR112016018062A8 (pt) compostos terapêuticos, composição farmacêutica e usos
BR112017014970A2 (pt) macrociclos de piridazinona como inibidores de irak e usos dos mesmos
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
BR112017028549A2 (pt) derivados de pirimidina como inibidores de btk e usos dos mesmos
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
PH12017500459A1 (en) Azetidinyloxyphenylpyrrolidine compounds
CR20170513A (es) Derivados de pirazol útiles como inhibidores de proteína activadora de 5-li-poxigenasa (flap).
BR112017000584A2 (pt) inibidores da aldosterona sintase
DOP2016000293A (es) Derivados de diheterociclo enlazado a cicloalquilo
BR112016018418A2 (pt) Composto, uso do mesmo, e composição farmacêutica
BR112018076734A2 (pt) compostos heterocíclicos anti-infecciosos e usos dos mesmos
BR112016028948A2 (pt) ?composição bifásica?

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements